Structural insights into SUMO E1-E2 interactions in Arabidopsis uncovers a distinctive platform for securing SUMO conjugation specificity across evolution by Liu, Bing et al.
This is the accepted version of the article:
Liu, Bing; Lois, L. Maria; Reverter i Cendrós, David. «Structural insights into
SUMO E1–E2 interactions in Arabidopsis uncovers a distinctive platform for
securing SUMO conjugation specificity across evolution». Biochemical Journal,
Vol. 476, Issue 14 (July 2019), p. 2127-2139. DOI 10.1042/BCJ20190232
This version is avaible at https://ddd.uab.cat/record/213943
under the terms of the license
 Structural insights into SUMO E1-E2 interactions in 
Arabidopsis uncovers a distinctive platform for securing 
SUMO conjugation specificity across evolution  
 
 
Bing Liu1, L. Maria Lois2 and David Reverter1* 
 
 
 
 
1Institut de Biotecnologia i de Biomedicina. Departament de Bioquimica i Biologia 
Molecular. Serra Hunter Fellow. Universitat Autonoma de Barcelona, 08193 
Barcelona, Bellaterra, Spain. 
2Center for Research in Agricultural Genomics-CRAG. Edifici CRAG-Campus 
UAB, Bellaterra 08193 Barcelona, Spain. 




*To whom the correspondence should be addressed: David Reverter, Universitat 
Autonòma de Barcelona, 08193 Bellaterra, Barcelona, Spain, Ph: +34 93 5868955, 
FAX: (93)5812011, E-mail: david.reverter@uab.cat  
ACCEPTED M
ANUSCRIPT 
10.1042/BCJ20190232
. Please cite using the DOI 10.1042/BCJ20190232http://dx.doi.org/up-to-date version is available at 
encouraged to use the Version of Record that, when published, will replace this version. The most 
 this is an Accepted Manuscript, not the final Version of Record. You are:Biochemical Journal
). http://www.portlandpresspublishing.com/content/open-access-policy#Archiving
Archiving Policy of Portland Press (
which the article is published. Archiving of non-open access articles is permitted in accordance with the 
Use of open access articles is permitted based on the terms of the specific Creative Commons Licence under
 ʹ
Abstract 
SUMOylation of proteins involves the concerted action of the E1-activating 
enzyme, E2-conjugating enzyme and E3-ligases. An essential discrimination step in 
the SUMOylation pathway corresponds to the initial interaction between E1 ubiquitin-
fold domain (UFD) and E2 enzymes. Although E2 orthologs possess high sequence 
identity, the E2 binding region of the UFD domains have diverged across evolution. 
Moreover, in reciprocal in vitro conjugation reactions Arabidopsis E1 and E2 SCE1 
fail to interact efficiently with cognate human E2 Ubc9 and E1 partners, respectively. 
To gain more insights into the properties of this interface in evolutionary distant 
organisms, we solved the crystal structure of SUMO E2 SCE1 and its complex with 
E1 UFD in Arabidopsis. In addition to a few common structural determinants, the 
interface between the E1 UFD and E2 in Arabidopsis is distinct compared with human 
and yeast, in particular by the presence of a longer α-helix in the Arabidopsis UFD 
domain. Despite the variability of E1 UFD domains in these surfaces, they establish 
specific interactions with highly conserved surfaces of their cognate E2 enzymes. 
Functional analysis of the different E2 interface residues between human and 
Arabidopsis revealed Val37 (Met36 in human), as a determinant that provides 
specificity in the E1-E2 recognition in plants. 
 ͵
1. Introduction 
Small ubiquitin-related modifier (SUMO) protein is one of the most extensively 
studied ubiquitin-like proteins (Ubls) present in eukaryotes. Yeast and invertebrates 
have a single SUMO protein named Smt3, while vertebrates have several SUMO 
proteins. Mammalians such as human express four SUMO proteins. SUMO2 and 
SUMO3 share 97% sequence identity and cannot be distinguished by antibodies 
[1,2]. However, SUMO1 is quite different from SUMO2/3 and only shares ~47% 
sequence identity with SUMO1 and SUMO2 [2]. In plants, SUMO conjugation 
machinery displays high complexity according to isoform number and variability [3,4]. 
Although only few studies have addressed the biological relevance of this molecular 
complexity [5–7], the diverse biological function of SUMOylation in plant development 
and plant responses to environmental stresses could benefit from the existence of 
isoforms dedicated to SUMOylate proteins under specific physiological conditions. 
Accordingly, increasing evidences suggest that a deep knowledge of plant 
SUMOylation could provide novel strategies for increasing crop productivity [4,8,9]. 
The best-characterized plant SUMOylation system belongs to Arabidopsis [6]. In 
Arabidopsis, there are eight encoding genes of SUMO isoforms (AtSUMO), but only 
AtSUMO1, AtSUMO2, AtSUMO3, and AtSUMO5 are expressed [10,11]. Among 
them, AtSUMO1 and AtSUMO2, which  share 83% sequence identity, are the highest 
expressed isoforms and double knock-out mutants sumo1sumo2 display embryo 
lethality [9,12–14].  
SUMO is conjugated to target proteins through a three-step enzyme cascade as 
ubiquitin via SUMO E1 activating enzyme, E2 conjugating enzyme, and E3 ligase 
[1,2]. In the model proposed for the SUMO/Ubl conjugation pathway, the E2 
conjugating enzyme interacts with the E1 activating enzyme by means of the UFD 
domain [15–18]. The structure of the UFD-E2 interaction is known for ubiquitin, 
Nedd8, and SUMO systems, showing a direct binding of E2 to the E1 UFD domain 
[17–23]. The UFD domain is located in the C-terminal end and connected to the E1 
active adenylation domain through a flexible hinge. During the thioester transfer 
between E1 and E2, the UFD domain undergoes a rotation to bring the catalytic 
cysteine residues of E1 and E2 into proximity for thioester transfer [17,18,24–26]. 
Moreover, crystal structure of ubiquitin E1-E2 complex reveals a direct interaction of 
E1 and E2 through their catalytic cysteine domains, which occurs after UFD-E2 
binding and a significant rotation of the UFD domain, providing structure insights for 
the E1 E2 thioester transfer [18,24]. This interaction was also proposed in the SUMO 
pathway by NMR analyses. However, UFD-E2 interactions (Kd= 1.2μM) display much 
 Ͷ
higher affinity than the catalytic cysteine domain interactions (Kd= 87μM), consistent 
with a major role of E1 UFD domain as the initial E2 binding platform [27].  
Structural and functional data indicate that the UFD-E2 interactions represent the 
first contacts between the E1-activating enzyme and the E2-conjugating enzyme, 
providing an important discrimination step for the pathway [28,29]. UFD-E2 
interactions have been revealed essential to provide specificity between the different 
systems of ubiquitin-like modifiers (i.e. SUMO, Nedd8, ubiquitin…). In the SUMO 
system, this interaction also provides specificity across species, despite the high 
homology between the E2-conjugating enzymes [30]. The UFD domains show little 
protein sequence homology across distant species, and it is even lower when 
considering just the E2 binding region or LHEB2 domain (Low Homology region 
involved in E2 Binding 2) [31]. However, the opposite is found in close related 
species, in which the LHEB2 domain display higher conservation than the UFD 
domain highlighting its crucial role [22,31]. 
Previous structural studies of the SUMO UFD-E2 complex in yeast and human 
revealed two alternative UFD interaction interfaces [20–22], in which particular 
contacts with a highly conserved E2 structure take place in each species. Despite the 
65% sequence identity between human and Arabidopsis SUMO E2 conjugating 
enzymes, human Ubc9 cannot complement Arabidopsis SCE1 in our in vitro 
conjugating assays using RanGAP1 as a model substrate, and vice versa. As a 
consequence of the amino acid sequence divergence found between Arabidopsis, 
human and yeast UFD domains, the study of Arabidopsis E1-E2 interactions cannot 
rely only on predictive models, and a structural analysis is required to reveal the 
particular contacts between Arabidopsis E1 and E2 enzymes. 
In order to elucidate the structural determinants for such exquisite evolutionary 
specificity in the interface of the UFD-E2 interaction, we have solved the crystal 
structure of the Arabidopsis E2-conjugating enzyme (AtSCE1), alone at a high 
resolution (1.2 Å) and in complex with the Arabidopsis UFD domain (AtUFD) of the 
E1-conjugating enzyme at 1.8 Å resolution. We have compared the Arabidopsis UFD-
E2 domain complex interface with the human and yeast systems and performed 
biochemical and mutagenesis analysis to understand the role of the interface in the 
specificity of the SUMO conjugation pathway. Our results indicate that Arabidopsis 
UFD provides a novel molecular strategy for E2 selection, not interchangeable with its 
human and yeast orthologs. 
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2. Materials and methods 
2.1 Cloning, protein expression and purification 
Expression constructs were generated by a standard PCR-based cloning method. 
Arabidopsis E1 heterodimers, SUMO1 and 2, SCE1, UFD and UFDC domain, as well 
as human E1 heterodimers, SUMO1 and 2, Ubc9, were cloned to pET28a tagged 
with 6×His at the N-terminal. Point mutations were created using the QuickChange 
site-directed mutagenesis kit (Stratagene). Escherichia coli BL21(DE3) plysS 
containing the expression vector were grown in Luria Bertani medium with 
chloramphenicol (17 μg/mL) and kanamycine (50 μg/mL) at 37 °C until the OD600 
reached to 0.8. Expression was induced by 0.1mM IPTG, followed by overnight 
culturing at 28 °C. Recombinant proteins were purified by nickel-nitrilotriacetic acid 
agarose resin (Qiagen) and dialyzed against 250 mM NaCl, 20 mM Tris-HCl (pH 8.0), 
1 mM β-mercaptoethanol in the presence of thrombin protease overnight at 4 °C to 
remove the 6×His tag. Proteins were further purified by gel filtration chromatography 
on a Superdex75 column (GE Healthcare), which was equilibrated in 250mM NaCl, 
20mM Tris-HCl pH 7.5, 1mM β-mercaptoethanol.  
 
2.2. Protein complex preparation and crystallization  
AtSCE1 and UFD or UFDC complexes were made by mixing equimolar amounts 
of proteins and purified by gel filtration chromatography using a Superdex75 column. 
AtSCE1 and UFD or UFDC were co-eluted in a single peak in buffer containing 100 
mM NaCl, HEPES pH 7.0, 1 mM β-mercaptoethanol, and confirmed by SDS-PAGE. 
Purified protein complex was concentrated to 15 g/L using an Amicon Ultra-10K 
ultrafiltration device (Millipore) prior to crystallization. Crystals were grown at 18 °C by 
the sitting-drop vapor diffusion method by mixing the protein with an equal volume of 
reservoir solution containing 0.1 M Bis-tris pH 5.5, 25% w/v PEG3350 for AtSCE1, or 
containing 15% PEG6000, 5% glycerol for UFDC-AtSCE1 complex. AtSCE1 crystals 
appeared after one week, while UFDC-AtSCE1 crystals appeared after several 
months. Big crystals were soaked in mother liquor supplemented with gradually 
increasing concentration of 5%, 10%, 20% (v/v) glycerol and flash frozen in liquid 
nitrogen.  
 
2.3. Data collection, structure determination and refinement 
Diffraction data were collected to 1.20 Å resolution for AtSCE1 and 1.8 Å for 
UFDC-AtSCE1 complex at ALBA synchrotron in Barcelona (BL13-XALOC beamline) 
[32]. Data were processed with XDS [33] and scaled, reduced, and further analyzed 
 ͸
using CCP4 [34]. More details are shown in Table 1. The structure of AtSCE1 was 
determined by molecular replacement method using the full length human Ubc9 (PDB 
code 1U9B) as a search model in PHASER [35]. The structure of UFDC-AtSCE1 
complex was determined by molecular replacement method using the solved AtSCE1 
as a search model in PHASER [35]. Initial electron density was manually improved to 
build up the final model using Coot [36], and the refinement was performed using 
Phenix [37]. Refinement statistics are shown in Table1.  
 
2.3. In vitro conjugation reaction and pull-down assays 
SUMO swapping conjugation assays were performed in reactions containing 20 
mM Bis-tris propane pH 8.5, 5 mM MgCl2, 0.1 Tween 20, 50 mM NaCl, 1m M DTT, 1 
mM ATP, 150 nM E1 heterodimer, 300 nM E2, 10 PM RanGAP1, and 10 PM SUMO 
protein. SUMO conjugation assays with mutants of the Arabidopsis SCE1 were 
performed in reactions containing the same buffer but with Bis-tris propane pH 7.5 
instead. Reactions were incubated at 37 °C and aliquots were mixed with loading 
buffer for analysis by SDS-PAGE, followed by staining with coomassie brilliant blue.  
Ni2+ Sepharose 6 Fast Flow beads (GE healthcare) were washed with assay 
buffer containing 100 mM NaCl, 20 mM Bis-tris propane pH 7.5, 0.1% Tween 20, 1 
mM DTT and incubated with 30 μg His-AtUFDC for 1 hour. The beads were then 
incubated with the same buffer containing 2 BSA for 1 hour to block the unspecific 
binding, followed by washing three times with the assay buffer. 10 μg of the untagged 
E2 was mixed in 300 μl of assay buffer and added in the beads, followed by 
incubation for 1 hour. The beads were then washed three times and elute with assay 
buffer containing 500 mM imidazole. Elution aliquots were mixed with loading buffer 
and analyzed by SDS-PAGE with coomassie brilliant blue staining.  
 
2.4. Temperature and urea induced unfolding assays 
The tryptophan fluorescence spectra of temperature induced unfolding 
measurements were taken at excitation wavelength 280 nM and emission 340 nM in 
PBS buffer containing 0.15 g/L proteins. Data collection was at temperature from 
25 °C to 80 °C with 1 °C steps and 1 minute between steps for equilibration in 
triplicates. Fraction unfolded was obtained by plotting the normalized fluorescence 
versus the corresponding temperatures. The urea induced unfolding were performed 
in PBS buffer by mixing 0.15 g/L proteins with increasing concentrations of urea (0 – 
9M) at 25 °C overnight to reach equilibrium. Tryptophan emission spectra of urea 
 ͹
induced unfolding were obtained by setting the excitation wavelength at 280 nM and 
collecting emission in the 300-400 nM range These spectra were quantified as the 
center of spectral mass (ν) according to equation ν = ΣνiFi/ΣFi where Fi stands for the 
fluorescence emission at a given wavelength (νi) and the summation is carried out 
over the range of appreciable values of F [38,39]. Fraction unfolded was obtained by 
plotting the normalized center of spectral mass versus the corresponding urea 
concentrations. All measurements were conducted using Jasco FP-8200 
spectrofluorimeter. Curves were generated using GraphPad Prism 7.0.  
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3. Results and discussion 
3.1. E1 and E2 enzymes are specific between human and Arabidopsis 
An intriguing question in the field deals with the lack of compatibility between 
enzymes of the SUMO conjugation pathway from different species, even though the 
high sequence identity present between E2 enzymes orthologs. We have conducted 
in vitro SUMO conjugation reactions swapping the SUMOylation components of 
Arabidopsis and human, including SUMO proteins, E1, and E2. Human RanGAP1, 
which contains the SUMO consensus motif Ψ-K-X-D/E [28,40], can be sufficiently 
conjugated by the SUMO machinery from both species, validating it as an in vitro 
universal SUMO substrate in E3-independent SUMO conjugation assays [41]. In 
conjugation assays containing human or Arabidopsis E1 and E2, the purified human 
RanGAP1 is quantitatively SUMOylated and migrates at ~32kD, consistent with the 
molecular weight of single SUMO modification (Fig. 1A,B).  
The results of SUMO swapping between human and Arabidopsis show 
differences in conjugation rate and SUMO ortholog specificity. Under our 
experimental conditions, the human E1 and E2 facilitate SUMO conjugation to 
RanGAP1 more efficiently than the Arabidopsis E1 and E2 pair. This higher efficiency 
is observed independently on the SUMO1 ortholog (hSUMO1, hSUMO2, AtSUMO1 or 
AtSUMO2) present in the assay. The Arabidopsis E1 and E2 pair catalyze the 
conjugation of AtSUMO1 and AtSUMO2 to RanGAP1 to a similar extend, consistently 
with results obtained using the plant substrate AtCAT3 [13], although with lower 
efficiency than the human E1 and E2. This reduced activity of the Arabidopsis E1 and 
E2 is more dramatic when the human SUMO1 or SUMO2 are included in the assay. 
(Fig. 1A,B). These results are consistent with a described role of Arabidopsis E1 in 
SUMO isoform selection [13], which has not been reported for human E1 up to date. 
The present results suggest the existence of molecular determinants in Arabidopsis 
E1 that contribute to confer higher selectivity in SUMO recognition than the human E1 
ortholog. Future structural analysis will be required to uncover these molecular 
determinants present in the Arabidopsis system, which we speculate could be the 
result of the higher divergence between SUMO isoforms present in plants. 
Nonetheless, these results show that SUMOs can be interchanged between systems 
at different levels, indicating that probably the observed complete incompatibility 
between species raises from the E2 interaction to E1 and/or to the SUMO-thioester 
transfer between E1 and E2 (Fig. 1C). 
E2-conjugating enzymes display a 65% sequence identity between human and 
Arabidopsis. When similar SUMO conjugation reactions were performed combining 
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human and Arabidopsis E1 and E2 enzymes, SUMOylated RanGAP1 could not be 
detected in trace amounts in the Arabidopsis E1 and human E2 combination after 120 
min reaction (Fig. 1D). These results indicate despite that the formation of the E1-
SUMO thioester could be achieved by combining human or plant SUMOs (Fig. 1A,C), 
the whole SUMO conjugation process relies on compatible interactions between E1 
and E2 enzymes, which are necessary for the SUMO-thioester transfer from the E1 to 
the E2-conjugating enzyme. This organism-dependent specificity between human and 
Arabidopsis E1 and E2 interaction is consistent with results obtained between human 
and P. falciparum systems [21,30]. 
 
3.2. Complex formation and crystallization 
To further define the E1-E2 interaction interface between human and Arabidopsis 
by protein crystallography, we have purified the recombinant Arabidopsis E2-
conjugating enzyme (AtSCE1) and the E1 UFD domain. AtSCE1 was expressed as a 
full-length protein (Met1 to Val160) in a pET28 vector, which includes a N-terminal 
His-tag extension to facilitate its purification. The UFD domain of the Arabidopsis E1-
activating enzyme was expressed in two different versions: a short version including 
only the UFD domain (Ubiquitin-like Fold Domain) from Ser436 to Thr549 (AtUFD); 
and a longer version including the C-terminal extension, from Ser436 to Glu625 
(AtUFDC). AtUFD and AtUFDC, were cloned in a pET28 vector, which includes a N-
terminal His-tag for affinity purification. Recombinant expression in E. coli of both 
proteins was successful and high protein amounts could be retrieved after the final 
purification step. 
Complex formation between AtSCE1 and AtUFDC or AtUFD was conducted by 
mixing equimolar amounts of both components and running a size-exclusion 
chromatography (Fig. 2A,B). The fractions of the complex were pooled and 
concentrated to set up crystallization screens. Interestingly, only the complex 
including the C-terminal extension of the UFD domain (AtUFDC) produced good 
diffraction quality crystals after several months at 18°C. The role of this C-terminal 
extension of the SAE2 E1 large subunit has not been completely clarified, although it 
might contribute to subcellular compartment localization both in human and 
Arabidopsis, as it contains a nuclear localization signal [7,42], but it does not seem 
relevant for the catalytic activity despite the presence of a SIM (SUMO interaction 
motif) observed in the active form of the SUMO E1 crystal structure [15,43]. 
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3.3. Structure of Arabidopsis E2 alone and in complex with the E1 UFD 
domain 
The structure of the Arabidopsis E2-conjugating enzyme, AtSCE1, was solved at 
1.2 Å resolution (Fig. 3A) (Table 1), which allows the visualization of structural details 
in the final electron density maps, such as the presence of residues with alternate 
conformations. Intriguingly, the final electron density reveals a double conformation of 
a 6 residues helical stretch in the C-terminal region of AtSCE1, between Tyr135 and 
Asp141. Despite this particular feature, the Arabidopsis AtSCE1 structure is highly 
similar to the structure of human Ubc9 (65% identity and rmsd=0.88 Å for 155 aligned 
residues) (Fig. 3D). The major differences in the backbone trace with human Ubc9 
(PDB code 1A3S) [44] corresponds to the β1-β2 loop, and to a small loop at the end 
of the β4 strand, produced by a 3 residue substitution (P-Q-G in A.thaliana, E-P-P in 
human) (Fig. 3D).  
We have also solved the crystal structure of AtSCE1 in complex with the UFDC 
domain of the Arabidopsis E1-activating enzyme at 1,8 Å resolution (Fig. 3C) (Table 
1), however the UFDC C-terminal extension was not observed in the final electron 
density maps. The structure of the complex was solved by molecular replacement 
using our previous AtSCE1 structure as a search model. As detailed later, the 
interface region in the AtSCE1 E2-conjugating enzyme comprises contacts in the α1 
helix and in the β1-β2 loop with the β-grasp fold of the E1 UFD domain (Fig. 3C), as 
expected from previous structures of the complex in human and yeast [20–22]. The 
structure of AtSCE1 in the complex is nearly identical to its isolated form (rmsd=0.35 
Å for 155 aligned residues), with the most notable difference being the slight variation 
in the β1-β2 loop conformation (Fig. 3B). Compared with a prior complex structure in 
human (5FQ2), AtSCE1 displays high degree of similarity with Ubc9 (rmsd=0.47 Å for 
155 aligned residues), with a slight shift in the β1-β2 loop to accommodate the AtUFD 
surface, but superimposition of the E2 moieties results in a shift in the orientation of 
their cognate UFD domains (Fig. 3E). Moreover, alignment of the UFD domains 
between human and Arabidopsis (30% identity and rmsd=1.30 Å for 93 aligned 
residues) also displays a notable rotation of SCE1 and Ubc9 across the β-grasp fold 
(Fig. 3F). Similar shifted orientations between the two moieties in the complex are 
also observed when compared with the yeast UFD-Ubc9 complex (Figs. 3G, H, I).  
 
3.4. Structural analysis of the interface between Arabidopsis E1 and E2. 
The binding surface in AtSCE1 resembles the structures of the complex in 
human and yeast, and it is formed by contacts between the α1 helix and the β1-β2 
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loop of AtSCE1. Major specific contacts include Val37, Leu39 and Met40 from the β1-
β2 loop and Arg7, Arg14, Lys15, Arg18 and Lys19 from the α1 helix basic patch (Fig. 
4A). Differences between human and Arabidopsis in the E2 contact residues are few, 
only the presence of Arg7 (leucine in human), Lys28 (valine in human) and Val37 
(Met36 in human) (Fig. 4B). Moreover, Glu67, which is not located in the SCE1 α1-
helix/β1-β2 binding module, forms a new hydrogen bond not present in human (Fig. 
4). Previous mutational analysis of human Ubc9 contact residues, such as the basic 
patch in α1 helix, revealed its major role for the interaction to the UFD E1 domain, 
and was proven to be essential for the transfer of SUMO between E1 and E2 
enzymes in the conjugation reaction [45]. Interestingly, despite their high conservation 
between human and Arabidopsis, E2-conjugating enzymes are not interchangeable in 
our in vitro conjugation assays (Fig. 1D).  
The structure of the AtUFD domain of Arabidopsis E1-activating enzyme displays 
a similar fold as the human or yeast counterparts (20% identity and rmsd=2.17 Å for 
91 aligned residues between Arabidopsis and yeast UFD). However, a major 
structural difference in AtUFD corresponds to the presence of a longer α2-helix (Fig. 
5A), resulting from a sequence insertion occurring in Arabidopsis (Fig. 5C). Residues 
from this novel longer α2 helix together with residues emanating from central β-sheet 
of the AtUFD (β4-β2-β3) directly participate in the interface with the E2 enzyme (Fig. 
5B). We have previously defined the interacting region between E2 and UFD E1 
domain as Low Homology region involved in E2 Binding 2 (LHEB2) [31], because it 
displays a lower homology in comparison to the rest of the UFD domain: i.e. UFD 
sequence identity between human and Arabidopsis is 31%, but is reduced to 11% 
when considering only the LHEB2 binding region. The LHEB2 can be divided in two 
regions, each establishing interactions with either the α1 helix or the β1-β2 loop of 
AtSCE1. Interestingly, a unique contact, not present in human or yeast, is observed in 
Arabidopsis between AtUFD Asn474 and AtSCE1 Glu67, a region far from the α1-
helix/β1-β2 loop module of the E2-conjugating enzyme (Fig. 5B). 
The first contact region in the AtUFD domain is composed by Glu479, Asp483 
and Glu516, which contact the positive charged groups of the AtSCE1 α1-helix 
(Arg14, Lys15, Arg18 and Lys19) and by Leu469 and Leu518, which are buried in a 
hydrophobic patch formed by the aliphatic side chain atoms of the aforementioned 
AtSCE1 α1 helix basic residues (Fig. 5B). Interestingly, Phe522 occupies this region 
in human, whereas in yeast it is occupied by Tyr489 (Fig. 5C,D), all of them buried in 
a similar aliphatic pocket wedged between basic residues of the AtSCE1 α1 helix [22]. 
Other contacts present in the AtSCE1 α1 helix include the unique Arg7 (leucine in 
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human), and Ala11, which interact with AtUFD Met471 (glutamine or leucine in 
human and yeast, respectively) (Fig. 5B,D).  
The second region of AtUFD E1 domain includes contacts with the β1-β2 loop 
surface of AtSCE1, and is composed by interactions from the β2-β3 loop and the 
longer α2 helix of AtUFD. Leu476, Asp485, Asn491, Tyr492 and Pro504 side chains 
are the major contacts within the AtUFD domain (Fig. 5B,C). In human and yeast this 
region is formed by a different type of contacts (Fig. 5C,D), only few similar to 
Arabidopsis: the central Leu476 (isoleucine and leucine in human and yeast, 
respectively) and the backbone hydrogen bond contacts between Asn474 and 
Leu476, with AtSCE1 Val37 and Leu39 (Fig. 5D).  
The analysis of the E1 UFD-E2 interfaces between Arabidopsis and human 
suggest that all contact residue substitutions in the UFD domain across species are 
accompanied by the compensatory residue substitutions to interact with the E2 
enzyme, suggesting a convergent co-evolution of the UFD domains to interact with 
the conserved residues of the E2 surface. Finally, the structural analysis of our UFD-
E2 complex in Arabidopsis in the present work confirms the impaired E2 binding 
interaction of two predicted AtUFD mutants (L476A, D485A) published previously 
[31].  
 
3.5. SUMO conjugation assays with mutants of the Arabidopsis SCE1 
Since SUMO modifier swapping was not a major issue for in vitro conjugation 
assays between human and Arabidopsis, we attribute the specificity of the SUMO 
conjugation reaction to the E1-E2 interaction (Fig. 1). This interaction has been 
proposed to be an essential recognition step for the recruitment of E2 on the E1-
conjugation enzyme surface. Our structural analysis indicates that the E2 surface in 
contact with the UFD domain is highly conserved between Arabidopsis and human 
(Fig. 4A,B), with only few modifications: Arg7-Gly8 (Leu-Ser in human); Lys28 (Val in 
human), and Val37 (Met in human) (Fig. 4A,B). To investigate the structural 
determinants for the specificity between Arabidopsis and human E2 enzymes, we 
have produced 5 different mutants in Arabidopsis AtSCE1 interface with the UFD 
domain: R7L; R7L/G8S; R7L/G8S/K28V; R7L/G8S/K28V/V37M; V37M. All residues in 
AtSCE1 have been replaced by the corresponding residues in human Ubc9 (Fig. 4B). 
Additionally, we have also assessed the role of the distinctive contact in Arabidopsis 
outside the α1-helix/β1-β2 loop module, by producing the AtSCE1 E67S point mutant.  
In vitro conjugation assays were conducted using the Arabidopsis enzymes with 
RanGAP1 as a model substrate. Replacement of AtSCE1 Arg7 and Gly8 (by Leu and 
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Ser in human, respectively), present at the beginning of the α1-helix, did not show 
any defect on the SUMO conjugation and displayed similar activities as the wild-type 
form (Fig. 6A). Regarding to AtSCE1 Lys28 (Val in human) and Val37 (Met in 
human), both present in the β1-β2 loop region, only Val37 had a strong effect on the 
conjugation activity (Fig. 6A). Such loss of the activity is probably caused by an E1 
binding defect, since the R7L/G8S/K28V/V37M and V37M mutants also showed a 
reduced UFD binding in pull-down assays (Fig. 6B). Finally, disruption of the unique 
contact described in A.thaliana, Glu67, only displayed a slight reduction in the 
conjugation activity (Fig. 6A,B). 
To further assess the relevance of the Val37 point mutant, protein stability 
assays were conducted with AtSCE1 wild type and the R7L/G8S/K28V/V37M tetra-
point mutant. Temperature-induced protein unfolding assays, indicate a similar 
thermal stability for the wild type AtSCE1 (Tm 48.4 °C) and R7L/G8S/K28V/V37M 
mutant (Tm 49.1 °C) (Fig. 6C). Also, urea-induced protein unfolding assays with wild 
type and R7L/G8S/K28V/V37M mutant displayed similar half transition concentration 
values of 2.6 M and 2.4 M urea, respectively (Fig. 6C). These results support the 
correct structural integrity for the AtSCE1 R7L/G8S/K28V/V37M mutant, probably 
attributing the SUMO conjugation impairment to a defect in the binding between UFD 
E1 and E2 enzymes caused by the Val37 substitution for methionine, as confirmed by 
the correct activity of the AtSCE1 R7L/G8S/K28V triple-mutant (Fig. 6A). 
It is worth mentioning here that the Arabidopsis AtSCE1 R7L/G8S/K28V/V37M 
tetra-mutant, in which most of the contacts with the UFD domain have been replaced 
for those in human Ubc9, do not display any SUMO conjugation when used as an E2 
with human SUMO1 or -2, human E1 and RanGAP1 (data not shown). These results 
indicate that the different specificities in SUMO conjugation between human and 
Arabidopsis not only rely on the highly conserved E1 UFD contact surface. Thus, 
despite the strong conservation between human and Arabidopsis E2 enzymes, 
surface residues outside the UFD interface in the E2 enzyme are also critical for 
SUMO specificity across species. Probably these residues outside the UFD interface 
are required for the interaction with other regions of the E1 enzyme, such as the E1 
Cys-domain, as observed in the crystal structures of the ubiquitin E1-E2 complexes 
captured during the ubiquitin trans-thiolation transfer [18,24].  
Interestingly, the different angle orientation of the SUMO E2 enzyme in complex 
with human, yeast and Arabidopsis SUMO UFD E1 domain probably contributes to 
provide specificity with its cognate E1 enzyme, thus it might elude steric clashes with 
other regions of the E1 enzyme during the catalytic trans-thiolation reaction. Our 
 ͳͶ
results are also consistent with the SUMO E2 specificity analysis conducted between 
human and Plasmodium falciparum [21,30], in which the SUMO conjugation reaction 
was only efficient only after the substitution of half of the E2 enzyme sequence 
between both species. 
  
 ͳͷ
4. Conclusion 
Our study provides the first detailed atomic structures of the Arabidopsis SUMO 
E2-conjugating enzyme, AtSCE1, alone and in complex with the UFD domain of the 
Arabidopsis SUMO E1-activating enzyme. This interaction between E1 and E2 
enzymes represents the initial step for the recruitment of the E2 enzyme to the SUMO 
conjugation pathway. The atomic details in the E1-E2 interface provided by our 
structure sheds light to the specificity displayed in the SUMO conjugation pathway 
across species, in which at least three different E1 UFD binding platforms, in human, 
yeast and plants, have evolved to interact with a highly conserved cognate E2 
enzyme. Our study suggests that this evolution is based on the interaction between 
the E2-conjugating enzyme and the E1 UFD domain, in which modifications on the 
UFD domain surface occur to compensate mutations that affect its interaction with the 
conserved surface of the E2 enzyme. Also, despite this high similarity in the E2 
conjugating enzymes in the E1 binding interface (more than 65% identity between 
human and Arabidopsis), they cannot be efficiently interchanged in our in vitro 
conjugation assays, indicating that these substitutions are critical for efficient cognate 
E1-E2 species-dependent recognition.  
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Table 1. Summary of crystallographic analysis 

Data collection 
 AtSCE1 AtSCE1 - AtUFD 
Beamline ALBA-XALOC ALBA-XALOC 
Space group P212121 P21 
Wave length (Å) 0.9793 0.9792 
Resolution (Å) 50.38-1.201 (1.205-1.201) 58.82-1.792 (1.798-1.792) 
a, b, c (Å) 32.90, 50.38, 93.78  36.16, 58.82, 70.23 
α, β, γ (°) α = β = γ = 90 α = γ = 90, β = 92.05 
Unique reflections  49524 26999 
Data redundancy 6.0 (6.2) 3.4 (3.3) 
Rmerge 0.14 (1.45) 0.094 (0.97) 
CC(1/2) 0.996 (0.642) 0.992 (0.581) 
I/σ 9.5 (2.2) 8.5 (1.7) 
Completeness (%) 99.9 (93.6) 99.9 (93.6) 
Refinement  
Resolution (Å) 44.38 – 1.20 45.08 – 1.80 
Non-anomalous reflections 49227 26964 
Rwork/Rfree 0.19/0.21 0.17/0.22 
Number of all atoms 1310 2212 
Number of waters 188 68 
RMSD bond (Å)/Angle (°) 0.014/1.50 0.017/1.62 
Ramachandran plot 
Favored (%) 95.52 97.30 
Allowed (%) 3.73 2.70 
Disallowed (%) 0.75 0 
 
 * Highest resolution shell is shown in parenthesis. 
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Figures Legends 
 
Fig. 1. SUMO conjugation assays exchanging SUMOs between human and 
Arabidopsis systems. A, SDS-PAGE analysis of the conjugation assays using human 
SUMO1 & 2 with E1 and E2 enzymes from human and Arabidopsis at pH 8.5. B, 
SDS-PAGE analysis of the conjugation assays using Arabidopsis SUMO1 & 2 with E1 
and E2 enzymes from human and Arabidopsis. C. Analysis of the SUMO-E1 and 
SUMO-E2 thioester formation (indicated with an ~ hyphen). Gels were run in the 
absence of b-mercaptoethanol. D, End-point reaction after 120 minutes of the 
heterologous conjugation assays combining SUMO1 and SUMO2 from human and 
Arabidopsis, respectively, with E1 and E2 enzymes from human and Arabidopsis. 
 
 
Fig 2. Purification of the complex between AtSCE1 and AtUFDC or AtUFD. Above, 
elution profile of the gel filtration purification (SUPERDEX 75 column) after mixing 
equimolar concentrations of AtSCE1 with either AtUFD (A), or AtUFDC (B) in a buffer 
containing 25mM HEPES 7.0, 100mM NaCl. Dotted lines indicated the elution 
volumes of the individual components. Below, SDS-PAGE analysis of the fractions of 
the elution peak is shown below. 
 
 
Fig 3. Crystal structure of the AtSCE1 and AtUFD-SCE1 complex. A, Cartoon 
representation of the structure of AtSCE1. B, Structural alignment of the isolated 
(yellow) and complexed (green) SCE1. C, Cartoon representation of the structure of 
AtUFD-SCE1 complex. Interface elements α1 helix and the β1-β2 loop of SCE1 are 
indicated. D, Structural alignment of the isolated AtSCE1 and human Ubc9 (PDB 
code 1A3S). Backbone differences are depicted. E, Superimposition of the AtUFD-
SCE1 complex on the human hUFD-Ubc9 complex (PDB code 5FQ2) by alignment of 
the SCE1 and human Ubc9. F, Superimposition of the AtUFD-SCE1 complex on the 
human hUFD-Ubc9 complex (PDB code 5FQ2) by alignment of the UFD domains. G, 
Structure alignment of the isolated AtSCE1 and yeast Ubc9 (PDB code 2GJD). H, 
Superimposition of the AtUFD-SCE1 complex on the yeast yUFD-Ubc9 complex 
(PDB code 3ONG) by alignment of the SCE1 and yUbc9. I, Superimposition of the 
AtUFD-SCE1 complex on the yeast yUFD-Ubc9 complex (PDB code 3ONG) by 
alignment of the UFD domains. 
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Fig 4. Structural and sequential comparison of Arabidopsis SCE1, human and yeast 
Ubc9. A, Cartoon and transparent electrostatic surface representation of AtSCE1, 
human Ubc9 and yeast Ubc9. Contact residues are labeled and shown in stick 
representation. B, Structural sequence alignment of Arabidopsis AtSCE1, human and 
yeast Ubc9. AtSCE1 domain secondary structure is shown on top. Red triangles 
indicate AtSCE1 contacts with AtUFD domain.  
 
 
Fig 5. Structural details and the comparison of the UFD domains. A, Cartoon 
representation of the structural overlapping of Arabidopsis AtUFD (blue) and human 
hUFD (red). B, stereo cartoon representation of the contacts between AtSCE1 (yellow 
thin ribbon) and AtUFD E1 domain (blue cartoon). Side-chain contact residues are 
labeled and shown in stick representation. C, Structural sequence alignment of the 
UFD domains of Arabidopsis (AtUFD), human (HsUFD) and yeast (ScUFD). AtUFD 
domain secondary structure is shown on top. Red triangles indicate AtUFD contacts 
with SCE1. Dotted red rectangle indicates the predicted LHEB2 region. D, Schematic 
representation of SUMO UFD domain contacts with the E2 enzymes from Arabidopsis, 
human (PDB code 5FQ2), and yeast (PDB code 3ONG).  
 
 
Fig 6. Activity, pull-down, and protein unfolding assays of AtSCE1 mutants. A, SDS-
PAGE of time-course SUMO conjugation assays of AtSCE1 mutants compared to the 
wild type AtSCE1 at pH 7.5. B, SDS-PAGE of the pull-down assays of wild type 
AtSCE1 (WT) and indicated AtSCE1 mutants. Panel below displays loading control 
for AtSCE1 wild type and mutants. C, Comparison of the temperature and urea 
induced protein unfolding curves of wild type AtSCE1 and the AtSCE1 
R7L/G8S/K28V/V37M mutant. 






